| Patient | Samuel Johnson |
|---|---|
| Date of birth | 1709-09-18 |
| Identifiers | MRN HR-EN008-SYN-TD; SSN (made up) 000-08-7139 |
| Document date | 2026-11-01 |
| Author | Catriona Bell, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
New patient visit for severe recurrent depression and lifelong tics: depression work-up, sertraline and psychotherapy, safety assessment, and a request for neurology consultation. Concerns: He cannot work, cannot face his friends, and fears he is losing his mind; He has lived with movements and sounds he cannot fully control since childhood and wants to know what they are. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-04-06 to 1765-05-18 | completed | S |
| Sertraline 100 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily in the morning | Oral route | 1765-05-18 | active | S |
| Ibuprofen 400 mg oral tablet, one tablet by mouth three times daily with food for five days | One tablet by mouth three times daily with food for five days | Oral route | 1765-08-31 to 1765-09-05 | completed | S |
| Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth daily while taking ibuprofen | One capsule by mouth daily before breakfast for five days | Oral route | 1765-08-31 to 1765-09-05 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Advance care planning conversation, about 18 minutes | 1765-07-27 to 1765-07-27 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1765-07-27 | Recombinant zoster vaccine, dose 1 of 2 | completed | S |
| 1765-07-27 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 1765-07-27 | Tdap vaccine | completed | S |
| 1765-07-27 | Hepatitis B vaccine (HepB-CpG), dose 1 of 2 | completed | S |
| 1765-09-28 | Recombinant zoster vaccine, dose 2 of 2 | completed | S |
| 1765-09-28 | Hepatitis B vaccine (HepB-CpG), dose 2 of 2 | completed | S |
| 1765-09-28 | Influenza vaccine, 1765-1766 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| early childhood | Scrofula (king's evil) in early childhood, leaving facial scars and no sight in one eye | D (CLM-0003) |
| from his youth | Motor and vocal tics and ritual stepping and counting behaviors, observed by friends from his youth onward | D (CLM-0009, CLM-0010, CLM-0011, CLM-0012) |
| 1729 | First severe episode of melancholy at about twenty, with despair and irritability; never afterwards perfectly relieved | D (CLM-0004) |
| 1764 | Very severe return of melancholy, with withdrawal from society, sighing, groaning, and restless pacing | D (CLM-0007) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Lifelong melancholy, in his son's words "a vile melancholy"; cause of death not recorded in the cited source | D (CLM-0002) | |
| wife | Died in 1752; cause not recorded in the cited source | D (CLM-0006) |
| Concern | Status | Evidence |
|---|---|---|
| He cannot work, cannot face his friends, and fears he is losing his mind | active | S |
| He has lived with movements and sounds he cannot fully control since childhood and wants to know what they are | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 14.6 on 1765-04-06; Sodium [Moles/volume] in Serum or Plasma 140 on 1765-04-06; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1765-04-06; Creatinine [Mass/volume] in Serum or Plasma 0.98 on 1765-04-06; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1760)/1.73 sq M 91 on 1765-04-06; Glucose [Mass/volume] in Serum or Plasma 94 on 1765-04-06; Thyrotropin [Units/volume] in Serum or Plasma 2.1 on 1765-04-06; Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma 412 on 1765-04-06; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 on 1765-04-06; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 on 1765-07-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 1765-09-28; Total score [MDQ] 3 on 1765-04-06; Total score [AUDIT-C] 0 on 1765-04-06; Cholesterol [Mass/volume] in Serum or Plasma 212 on 1765-07-27; Cholesterol in HDL [Mass/volume] in Serum or Plasma 46 on 1765-07-27; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 138 on 1765-07-27; Triglyceride [Mass/volume] in Serum or Plasma 140 on 1765-07-27; Hemoglobin A1c/Hemoglobin.total in Blood 5.5 on 1765-07-27; Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay 0.07 on 1765-07-27; Hepatitis B virus surface Ab [Units/volume] in Serum 2 on 1765-07-27 [S]
Strengths and supports: Widower for thirteen years; shares his home with several longtime friends whom he supports; many close friends, whose company he seeks because he dreads being alone [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Major depressive disorder, recurrent, severe, without psychotic features: low mood, loss of interest, poor sleep, guilt, and withdrawal from company for about three months on a background of depression that never fully lifted after a severe episode last year; first episode at about twenty; synthetic modern episode linked to his documented melancholy | active | confirmed | F33.2 | S — Synthetic modern diagnosis by DSM-5 criteria; the record makes no claim about his real mental health. |
| Motor and vocal tics since childhood, with ritual counting and stepping behaviors, never formally diagnosed; neurology evaluation requested | resolved | confirmed | F95.9 | S — Synthetic presenting concern anchored to the documented tics; superseded by the diagnosis at the neurology consultation. |
| Tourette syndrome: multiple motor tics and vocal tics since childhood, with premonitory urges, brief suppressibility, and tic-related obsessive-compulsive symptoms (counting, evening-up, and threshold rituals); synthetic modern diagnosis by DSM-5 criteria at the neurology consultation, linked to the documented tics and to the retrospective diagnosis | active | confirmed | F95.2 | S — Synthetic modern diagnosis; the retrospective historical diagnosis is graded R and is not asserted as fact. |
| Blindness of the left eye since early childhood after scrofula (tuberculous cervical lymphadenitis), with old scars of the neck and face; right eye myopic, corrected to normal; synthetic modern coding linked to his documented loss of sight in one eye | active | confirmed | H54.42 | S — Synthetic modern coding; the source does not say which eye, so the left is a synthetic choice. |
| Acute low back strain after lifting boxes of books, without radicular symptoms or red flags; treated with heat, activity, and a short course of ibuprofen with stomach protection; resolved | resolved | confirmed | S39.012A | S — Synthetic acute problem; not a historical claim. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1765-04-06 | Hemoglobin [Mass/volume] in Blood | 14.6 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1765-04-06 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-145 mmol/L | Normal | S |
| 1765-04-06 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1765-04-06 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 1765-04-06 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1760)/1.73 sq M | 91 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1765-04-06 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 1765-04-06 | Thyrotropin [Units/volume] in Serum or Plasma | 2.1 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 1765-04-06 | Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma | 412 | pg/mL | 232-1245 pg/mL | Normal | S |
| 1765-04-06 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 24 | U/L | 7-56 U/L | Normal | S |
| 1765-04-06 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 21 | {score} | S | ||
| 1765-04-06 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 12 | {score} | S | ||
| 1765-04-06 | Total score [MDQ] | 3 | {score} | S | ||
| 1765-04-06 | Total score [AUDIT-C] | 0 | {score} | S | ||
| 1765-04-20 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 19 | {score} | S | ||
| 1765-05-18 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 15 | {score} | S | ||
| 1765-05-18 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 9 | {score} | S | ||
| 1765-06-22 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 10 | {score} | S | ||
| 1765-09-28 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 1765-09-28 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 1765-07-27 | Cholesterol [Mass/volume] in Serum or Plasma | 212 | mg/dL | <=199 mg/dL | High | S |
| 1765-07-27 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 | mg/dL | >=40 mg/dL | Normal | S |
| 1765-07-27 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 138 | mg/dL | <=129 mg/dL | High | S |
| 1765-07-27 | Triglyceride [Mass/volume] in Serum or Plasma | 140 | mg/dL | <=149 mg/dL | Normal | S |
| 1765-07-27 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | % | <=5.6% | Normal | S |
| 1765-07-27 | Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay | 0.07 | {s_co_ratio} | Below 1.00 is nonreactive | Normal | S |
| 1765-07-27 | Hepatitis B virus surface Ab [Units/volume] in Serum | 2 | m[IU]/mL | 10 mIU/mL or more indicates immunity | Low | S |
| 1765-07-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1765-04-06 | Body height | 183 | cm | S |
| 1765-04-06 | Body weight | 98 | kg | S |
| 1765-04-06 | Body mass index (BMI) [Ratio] | 29.3 | kg/m2 | S |
| 1765-04-06 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1765-04-06 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1765-04-06 | Heart rate | 84 | /min | S |
| 1765-04-06 | Respiratory rate | 16 | /min | S |
| 1765-04-06 | Body temperature | 36.7 | Cel | S |
| 1765-04-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1765-04-20 | Body height | 183 | cm | S |
| 1765-04-20 | Body weight | 97.6 | kg | S |
| 1765-04-20 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 1765-04-20 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1765-04-20 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1765-04-20 | Heart rate | 80 | /min | S |
| 1765-04-20 | Respiratory rate | 16 | /min | S |
| 1765-04-20 | Body temperature | 36.6 | Cel | S |
| 1765-04-20 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1765-05-18 | Body height | 183 | cm | S |
| 1765-05-18 | Body weight | 98.2 | kg | S |
| 1765-05-18 | Body mass index (BMI) [Ratio] | 29.3 | kg/m2 | S |
| 1765-05-18 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1765-05-18 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1765-05-18 | Heart rate | 78 | /min | S |
| 1765-05-18 | Respiratory rate | 14 | /min | S |
| 1765-05-18 | Body temperature | 36.7 | Cel | S |
| 1765-05-18 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1765-06-22 | Body height | 183 | cm | S |
| 1765-06-22 | Body weight | 98.6 | kg | S |
| 1765-06-22 | Body mass index (BMI) [Ratio] | 29.4 | kg/m2 | S |
| 1765-06-22 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1765-06-22 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1765-06-22 | Heart rate | 76 | /min | S |
| 1765-06-22 | Respiratory rate | 14 | /min | S |
| 1765-06-22 | Body temperature | 36.6 | Cel | S |
| 1765-06-22 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1765-09-28 | Body height | 183 | cm | S |
| 1765-09-28 | Body weight | 98.8 | kg | S |
| 1765-09-28 | Body mass index (BMI) [Ratio] | 29.5 | kg/m2 | S |
| 1765-09-28 | Systolic blood pressure | 122 | mm[Hg] | S |
| 1765-09-28 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1765-09-28 | Heart rate | 74 | /min | S |
| 1765-09-28 | Respiratory rate | 14 | /min | S |
| 1765-09-28 | Body temperature | 36.6 | Cel | S |
| 1765-09-28 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1765-07-27 | Body height | 183 | cm | S |
| 1765-07-27 | Body weight | 98.4 | kg | S |
| 1765-07-27 | Body mass index (BMI) [Ratio] | 29.4 | kg/m2 | S |
| 1765-07-27 | Systolic blood pressure | 124 | mm[Hg] | S |
| 1765-07-27 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1765-07-27 | Heart rate | 72 | /min | S |
| 1765-07-27 | Respiratory rate | 14 | /min | S |
| 1765-07-27 | Body temperature | 36.6 | Cel | S |
| 1765-07-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1765-08-31 | Body height | 183 | cm | S |
| 1765-08-31 | Body weight | 98.6 | kg | S |
| 1765-08-31 | Body mass index (BMI) [Ratio] | 29.4 | kg/m2 | S |
| 1765-08-31 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1765-08-31 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1765-08-31 | Heart rate | 82 | /min | S |
| 1765-08-31 | Respiratory rate | 14 | /min | S |
| 1765-08-31 | Body temperature | 36.7 | Cel | S |
| 1765-08-31 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1765-04-06 | New patient visit for severe recurrent depression and lifelong tics: depression work-up, sertraline and psychotherapy, safety assessment, and a request for neurology consultation | finished | S |
| 1765-04-20 | Two-week depression check and neurology consultation | finished | S |
| 1765-05-18 | Six-week depression review: sertraline dose increase; behavioral therapy for tics under way | finished | S |
| 1765-06-22 | Eleven-week review of depression and tics | finished | S |
| 1765-09-28 | Six-month review of depression and tics | finished | S |
| 1765-07-27 | Periodic adult preventive visit | finished | S |
| 1765-08-31 | Same-day sick visit for acute low back pain | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Sertraline started at 50 mg daily with a two-week tolerability check, and the dose adjusted by the PHQ-9 | completed | GL-CMID-2026, GL-MDD-2022 | S |
| Weekly cognitive behavioral therapy for depression, with behavioral activation and work on self-reproach | completed | GL-MDD-2022, GL-CMID-2026 | S |
| PHQ-9 at every visit, structured safety assessment with a written safety plan and the 988 Suicide & Crisis Lifeline, safety review at every visit, and a nurse phone check one week after starting | completed | GL-CMID-2026, GL-USPSTF-DEP-2023, GL-SUICIDE-2024 | S |
| Neurology consultation to confirm the tic disorder, exclude other movement disorders, assess obsessive-compulsive symptoms, and advise on treatment | completed | GL-AAN-TICS-2019 | S |
| Comprehensive Behavioral Intervention for Tics (CBIT), eight sessions over ten weeks with a trained therapist, with psychoeducation for him and, if he wishes, his household | completed | GL-AAN-TICS-2019 | S |
| Tic severity measured with the Yale Global Tic Severity Scale at the consultation and at three and six months; tic medication held in reserve | completed | GL-AAN-TICS-2019 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| PHQ-9 response (at least a 50% fall) by three months and remission (below 5) by six months | 1765-09-28 | completed | PHQ-9 10 at eleven weeks (from 21) and 4 at six months | S |
| Back at daily writing and seeing friends again by three months | 1765-06-22 | completed | Writing most mornings and dining with friends several times a week | S |
| Fewer and less disruptive tics, judged by him and by the tic severity scale, by six months | 1765-09-28 | completed | Yale Global Tic Severity Scale total tic score 22 from 30 and impairment 10 from 20; he finds the remaining tics manageable | S |
| Safety plan in place and reviewed at every visit | 1765-09-28 | completed | Reviewed at every visit; no suicidal thoughts at any visit | S |
Structured synthetic safety assessment on 1765-04-06: current ideation absent, intent absent, plan absent. Outpatient care with close follow-up because the depression is severe: weekly psychotherapy, a nurse phone check in one week, and a visit in two weeks. No current thoughts of suicide or self-harm, and no firearms or stockpiled medicines at home. A written safety plan was made with him and the 988 Suicide & Crisis Lifeline was given. Safety reviewed at every visit [S]